Full Product Name
AMHR2 antibody
Product Synonym Names
AMHR; MRII; MISR2; MISRII
Product Gene Name
anti-AMHR2 antibody
[Similar Products]
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
3D Structure
ModBase 3D Structure for Q16671
Specificity
The antibody detects endogenous level of total AMHR2 antibody.
Purity/Purification
Antibodies were purified by affinity purification using immunogen.
Form/Format
Supplied at 1.0mg/mL in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Concentration
1.0 mg/ml (lot specific)
Immunogen Type
Recombinant Protein
Immunogen Description
Recombinant protein of human AMHR2.
Preparation and Storage
Store at -20 degree C
Other Notes
Small volumes of anti-AMHR2 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Related Product Information for
anti-AMHR2 antibody
This gene encodes the receptor for the anti-Mullerian hormone (AMH) which, in addition to testosterone, results in male sex differentiation. AMH and testosterone are produced in the testes by different cells and have different effects. Testosterone promotes the development of male genitalia while the binding of AMH to the encoded receptor prevents the development of the mullerian ducts into uterus and Fallopian tubes. Mutations in this gene are associated with persistent Mullerian duct syndrome type II. Alternatively spliced transcript variants encoding different isoforms have been identified.
Product Categories/Family for anti-AMHR2 antibody
Total protein Ab
Applications Tested/Suitable for anti-AMHR2 antibody
Western Blot (WB)
Application Notes for anti-AMHR2 antibody
Western blotting: 1:500 - 1:2000
Western Blot (WB) of anti-AMHR2 antibody
Western blot analysis of extracts of various cell lines, using AMHR2 antibody.

NCBI/Uniprot data below describe general gene information for AMHR2. It may not necessarily be applicable to this product.
NCBI Accession #
NP_001158162.1
[Other Products]
NCBI GenBank Nucleotide #
NM_001164690.1
[Other Products]
UniProt Primary Accession #
Q16671
[Other Products]
UniProt Secondary Accession #
Q13762; Q647K2; A0AVE1; B9EGB7; E9PGD2; F8W1D2[Other Products]
UniProt Related Accession #
Q16671[Other Products]
Molecular Weight
51,827 Da
NCBI Official Full Name
anti-Muellerian hormone type-2 receptor isoform 2
NCBI Official Synonym Full Names
anti-Mullerian hormone receptor, type II
NCBI Official Symbol
AMHR2??[Similar Products]
NCBI Official Synonym Symbols
AMHR; MRII; MISR2; MISRII
??[Similar Products]
NCBI Protein Information
anti-Muellerian hormone type-2 receptor
UniProt Protein Name
Anti-Muellerian hormone type-2 receptor
UniProt Synonym Protein Names
Anti-Muellerian hormone type II receptor; AMH type II receptor; MIS type II receptor; MISRII; MRII
Protein Family
Anti-Muellerian hormone type-2 receptor
UniProt Gene Name
AMHR2??[Similar Products]
UniProt Synonym Gene Names
AMHR; MISR2; AMH type II receptor; MISRII; MRII??[Similar Products]
UniProt Entry Name
AMHR2_HUMAN
NCBI Summary for AMHR2
This gene encodes the receptor for the anti-Mullerian hormone (AMH) which, in addition to testosterone, results in male sex differentiation. AMH and testosterone are produced in the testes by different cells and have different effects. Testosterone promotes the development of male genitalia while the binding of AMH to the encoded receptor prevents the development of the mullerian ducts into uterus and Fallopian tubes. Mutations in this gene are associated with persistent Mullerian duct syndrome type II. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Sep 2009]
UniProt Comments for AMHR2
MISR2: On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators. Receptor for anti-Muellerian hormone. Belongs to the protein kinase superfamily. TKL Ser/Thr protein kinase family. TGFB receptor subfamily.
Protein type: Kinase, protein; EC 2.7.11.30; Protein kinase, TKL; Membrane protein, integral; Protein kinase, Ser/Thr (receptor); TKL group; STKR family; Type2 subfamily
Chromosomal Location of Human Ortholog: 12q13
Cellular Component: integral to plasma membrane
Molecular Function: protein binding; hormone binding; transforming growth factor beta receptor activity, type II; metal ion binding; receptor activity; ATP binding; receptor signaling protein serine/threonine kinase activity
Biological Process: Mullerian duct regression; transforming growth factor beta receptor signaling pathway; signal transduction; protein amino acid phosphorylation; sex differentiation
Disease: Persistent Mullerian Duct Syndrome, Types I And Ii
Research Articles on AMHR2
1. Data indicate that Muellerian inhibiting substance type II receptor (MISRII) is a promising target for the control of ovarian granulosa cell tumors (GCT) and epithelial ovarian cancers (EOC).
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.